AMGN

Amgen

$350.95

+1.13 (+0.32%)
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...

Analyst Overview

Target Price:
Date: 15.04.2026
$351.69
(+0.21%)
Strong Buy: 4
Buy: 9
Hold: 18
Sell: 2
Strong Sell: 1
Description:
Amgen Inc. (formerly Applied Molecular Genetics Inc.) is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. Focused on molecular biology and biochemistry, its goal is to provide a healthcare business based on recombinant DNA technology.
Exchange:
NASDAQ
Country:
USA
Sector:
HEALTHCARE
Industry:
DRUG MANUFACTURERS - GENERAL
Address:
ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA, UNITED STATES, 91320-1799
Fiscal year end:
December
Market capitalization:
$189 Billion
EBITDA:
$16.6 Billion
PERatio:
24.57
EPS:
14.24
Dividend per share:
$9.52
Dividend yield:
2.71%
Beta:
0.465

Dividends for 10 years

Loading...

Income Statements for 10 years

Loading...
Loading...

Earnings calender

Loading...

Income count if spend 1000$ ten years ago on shares

How much was you spent on shares:
$1,000
How much will you earn in 10 years:
+216%
How much will you get:
$3,157
Prices dates:
31-03-2016: $111.46 and 31-03-2026: $351.85